CardioRenal has developed the first in the world connected self-test allowing Heart Failure or Kidney disease patients to monitor their blood potassium at home as easily as diabetic patients measure their glycemia. The device, TENOR, has been validated in a clinical study in Brussels. TENOR, is currently going through CE clinical trial and has been granted « breakthrough device label » by FDA. Commercialisation in Europe will start in 2024.
December 3rd & 4th, 2024
IN-PERSON | LILLE, FR
December 11th & 12th, 2024
DIGITAL MEETINGS
MedFIT is your unique opportunity to connect with international key innovators in the MedTech, diagnostic and digital health sectors. As a leading European partnering event, MedFIT provides the ideal environment to build partnerships for all public and private actors, to source innovative and competitive early-stage R&D projects, to speed the emergence of collaborative projects, to increase licensing opportunities, to obtain funding and to facilitate market access.
Learn more
Organised by:
With the support of:
INSTITUTIONAL PARTNERS
Keep up to date with the latest news from MedFIT!
Monthly newsletter
"*" indicates required fields
Event venue
Lille Grand Palais
1, Boulevard des Cités Unies
59777 Lille, FRANCE
Legal terms
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
WARNING: Some fraudulent companies are supposedly providing the attendees list of MedFIT. And some are passing themselves off as being MedFIT organisation members and asking you to pay. Please note that the MedFIT team will never sell you the MedFIT attendees list and never ask for your bank account details to make you pay for hotel bookings, exhibition fees or others, and certainly not over the phone.Please be extremely vigilant.